Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Cannabidiol Treatment in Patients With Early Psychosis (CBD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02504151
Recruitment Status : Active, not recruiting
First Posted : July 21, 2015
Last Update Posted : November 27, 2019
Sponsor:
Information provided by (Responsible Party):
Mohini Ranganathan, Yale University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 2020
Estimated Study Completion Date : December 2020